ExLibris header image
SFX Logo
Title: Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Fananapazir, L yr:1993


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Schreuder, L T W W. "Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction." Journal of inherited metabolic disease 33.3 (2010): 205-209. Link to Full Text for this item Link to SFX for this item
2. Nishi, H. "A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy." Circulation 91.12 (1995): 2911-5. Link to SFX for this item
3. Salomon, Joshua A. "Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010." Lancet 380.9859: 2129-2143. Link to SFX for this item
4. Tiziano, S. "Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design." Journal of medical genetics 47.12 (2010): 856-858. Link to SFX for this item
5. Messina, S. "Pilot trial of salbutamol in central core and multi-minicore diseases." Neuropediatrics 35.5 (2004): 262-6. Link to SFX for this item
6. Bashyam, Murali D D. "Molecular genetics of familial hypertrophic cardiomyopathy (FHC)." Journal of human genetics 48.2 (2003): 55-64. Link to Full Text for this item Link to SFX for this item
7. Salomon, Joshua A. "Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010." Lancet 380.9859: 2144-2162. Link to SFX for this item
8. Lim, S. "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010." Lancet 380.9859: 2224-2260. Link to SFX for this item
9. Murray, Christopher J. "GBD 2010: design, definitions, and metrics." Lancet 380.9859: 2063-2066. Link to SFX for this item
10. Lozano, R. "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010." Lancet 380.9859: 2095-2128. Link to SFX for this item
11. Alonso, J. "Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys." Psychological Medicine 41.4 (2011): 873-886. Link to SFX for this item
12. Pane, M. "Daily salbutamol in young patients with SMA type II." Neuromuscular Disorders 18.7 (2008): 536-40. Link to SFX for this item
13. Chong, Jessica X. "A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites." European journal of human genetics 19.10 (2011): 1045-1051. Link to Full Text for this item Link to SFX for this item
14. Sendtner, M. "Therapy development in spinal muscular atrophy." Nature Neuroscience 13.7 (2010): 795-799. Link to SFX for this item
15. Soliven, B. "Terbutaline in myasthenia gravis: a pilot study." Journal of the Neurological Sciences 277.1-2 (2009): 150-4. Link to SFX for this item
16. Rossier, Bernard C C. "Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors." Annual Review of Physiology 64.1 (2002): 877-97. Link to Full Text for this item Link to SFX for this item
17. Tardiff, C.. "Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes." Heart failure reviews 10.3 (2005): 237-248. Link to SFX for this item
18. Bonne, G. "Familial Hypertrophic Cardiomyopathy From Mutations to Functional Defects." Circulation research 83.6 (1998): 580-593. Link to SFX for this item
19. Maron, Maron J. "Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy." Journal of cardiovascular electrophysiology 19.10 (2008): 1118-1126. Link to Full Text for this item Link to SFX for this item
20. Angelozzi, C. "Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells." Journal of medical genetics 45.1 (2007): 29-31. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced